Published in Respir Res on September 27, 2006
Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells. Am J Respir Cell Mol Biol (2011) 0.98
Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication. Antioxid Redox Signal (2009) 0.94
Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43. Am J Pathol (2011) 0.92
Idiopathic pulmonary fibrosis and cancer: do they really look similar? BMC Med (2015) 0.88
Hyperoxia arrests pulmonary development in newborn rats via disruption of endothelial tight junctions and downregulation of Cx40. Mol Med Rep (2014) 0.80
Polycyclic aromatic hydrocarbon-induced signaling events relevant to inflammation and tumorigenesis in lung cells are dependent on molecular structure. PLoS One (2013) 0.78
Alveolar epithelial disintegrity in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2016) 0.76
The role of gap junctions in inflammatory and neoplastic disorders (Review). Int J Mol Med (2017) 0.76
Carbenoxolone induces apoptosis and inhibits survivin and survivin-ΔEx3 genes expression in human leukemia K562 cells. Daru (2011) 0.76
Note on a possible proarrhythmic property of antiarrhythmic drugs aimed at improving gap-junction coupling. Biophys J (2012) 0.75
Connexins, Pannexins, and Their Channels in Fibroproliferative Diseases. J Membr Biol (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med (1998) 6.22
The gap junction communication channel. Cell (1996) 5.95
Gap junctions: new tools, new answers, new questions. Neuron (1991) 4.93
Gap junctions and the connexin protein family. Cardiovasc Res (2004) 3.66
The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol (1991) 3.35
Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol (1990) 3.32
An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis (1989) 3.12
Rapid turnover of connexin43 in the adult rat heart. Circ Res (1998) 2.75
Five-hour half-life of mouse liver gap-junction protein. J Cell Biol (1981) 2.65
Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J Pharmacol Exp Ther (1988) 2.31
Comparative characterization of the 21-kD and 26-kD gap junction proteins in murine liver and cultured hepatocytes. J Cell Biol (1989) 2.11
The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol (2004) 1.95
Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs. Am J Physiol (1992) 1.95
Role of connexin genes in growth control. Carcinogenesis (1996) 1.72
Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis (1988) 1.68
Gap junctions. Int Rev Cytol (1993) 1.67
Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J Biol Chem (2000) 1.62
How to close a gap junction channel. Efficacies and potencies of uncoupling agents. Methods Mol Biol (2001) 1.61
Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative. Exp Cell Res (1996) 1.41
Different expression of TNF-alpha receptors and prostaglandin E(2 )Production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol (2000) 1.31
Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol (1999) 1.19
Cytosolic stress reduces degradation of connexin43 internalized from the cell surface and enhances gap junction formation and function. Mol Biol Cell (2005) 1.14
Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. Am J Med (1968) 1.12
Gap junctions and connexin-mediated communication in the immune system. Biochim Biophys Acta (2004) 1.12
Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int (2003) 1.11
Gap junctions, homeostasis, and injury. J Cell Physiol (2002) 1.11
Virtual cloning, functional expression, and gating analysis of human connexin31.9. Am J Physiol Cell Physiol (2002) 1.10
Role of connexin (gap junction) genes in cell growth control and carcinogenesis. C R Acad Sci III (1999) 1.08
Gap junction function and cancer. Cancer Res (1993) 1.04
The human connexin gene family of gap junction proteins: distinct chromosomal locations but similar structures. Genomics (1991) 1.03
Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43. Carcinogenesis (1998) 1.02
Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. Carcinogenesis (2004) 0.99
Role of gap junctions during early embryo development. Reproduction (2005) 0.98
Gap-junctional coupling measured by flow cytometry. Exp Cell Res (2000) 0.96
Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J Invest Dermatol (1998) 0.93
Six genes of the human connexin gene family coding for gap junctional proteins are assigned to four different human chromosomes. Eur J Cell Biol (1990) 0.89
Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells. Carcinogenesis (1998) 0.89
Normal human lung fibroblasts differently modulate interleukin-10 and interleukin-12 production by monocytes: implications for an altered immune response in pulmonary chronic inflammation. Am J Respir Cell Mol Biol (2001) 0.88
Cisplatin-induced premature senescence with concomitant reduction of gap junctions in human fibroblasts. Cell Res (2004) 0.85
Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer? J Epidemiol Community Health (1998) 0.85
Effective asymmetry in gap junctional intercellular communication between populations of human normal lung fibroblasts and lung carcinoma cells. Carcinogenesis (2003) 0.83
Role of gap junctions in lung neoplasia. Exp Lung Res (1998) 0.83
Connexin 26 expression and mutation analysis in epidermal disease. Cell Commun Adhes (2001) 0.80
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med (2007) 5.31
Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 2.06
The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol (2004) 1.95
A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Ann Ital Med Int (2004) 1.46
TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res (2008) 1.40
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One (2010) 1.15
Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms. PLoS One (2011) 1.04
Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir Res (2005) 1.01
Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther (2003) 1.00
16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis. Am J Respir Cell Mol Biol (2008) 0.96
Idiopathic pulmonary fibrosis: an update. Ann Med (2015) 0.94
Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML. Leuk Res (2010) 0.94
Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events. Adv Ther (2014) 0.94
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respir Res (2006) 0.94
Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Exp Lung Res (2011) 0.92
Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial. Respir Res (2012) 0.92
Protective effect of orally administered carnosine on bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2007) 0.91
Erratic expression of DNA polymerases by beta-amyloid causes neuronal death. FASEB J (2002) 0.90
Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts. J Cell Physiol (2007) 0.89
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases. J Cell Biochem (2005) 0.88
Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung. Eur J Clin Invest (2013) 0.87
The p53-homologue p63 may promote thyroid cancer progression. Endocr Relat Cancer (2005) 0.87
Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Ann Allergy Asthma Immunol (2006) 0.86
PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition. Lab Invest (2013) 0.85
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis. Eur Respir J (2013) 0.83
Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction. J Allergy Clin Immunol (2003) 0.83
Subsegmental pulmonary embolism: value of thoracic ultrasound for diagnosis and follow-up. Intern Med (2008) 0.82
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors. J Proteomics (2013) 0.82
Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update. Curr Opin Pulm Med (2015) 0.81
Interferon-γ and interleukin-17 production from PPD-stimulated PBMCss of patients with pulmonary tuberculosis. Clin Invest Med (2013) 0.81
Montelukast protects against bradykinin-induced bronchospasm. J Allergy Clin Immunol (2005) 0.80
Astrocyte-like cells as a main target for estrogen action during neuronal differentiation. Mol Cell Neurosci (2006) 0.80
Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma. J Oral Pathol Med (2013) 0.79
Human lung fibroblasts increase CD4(+)CD25(+)Foxp3(+) T cells in co-cultured CD4(+) lymphocytes. Cell Immunol (2013) 0.79
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells. Respir Res (2005) 0.79
Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review. Insights Imaging (2014) 0.79
Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis. Expert Opin Biol Ther (2015) 0.79
Activation of cytosolic phospholipase A2 and 15-lipoxygenase by oxidized low-density lipoproteins in cultured human lung fibroblasts. Biochim Biophys Acta (2007) 0.78
Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. Oncol Res (2004) 0.78
Bradykinin differentiates human lung fibroblasts to a myofibroblast phenotype via the B2 receptor. J Allergy Clin Immunol (2005) 0.78
Protective effects of thymosin β4 in a mouse model of lung fibrosis. Ann N Y Acad Sci (2012) 0.78
Bioassay-guided isolation of antiproliferative compounds from grape (Vitis vinifera) stems. Nat Prod Commun (2009) 0.78
Beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: correlation with the MAP kinase pathway. J Mol Neurosci (2004) 0.78
Differentiation of human adipose stem cells into neural phenotype by neuroblastoma- or olfactory ensheathing cells-conditioned medium. J Cell Physiol (2013) 0.77
Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C. Front Biosci (Elite Ed) (2010) 0.76
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction. Respir Med (2010) 0.75
Antiproliferative effects induced by guanine-based purines require hypoxanthine-guanine phosphoribosyltransferase activity. Biol Chem (2010) 0.75
The effect of fexofenadine on expression of intercellular adhesion molecule 1 and induction of apoptosis on peripheral eosinophils. Allergy Asthma Proc (2005) 0.75
Recent advances in molecular diagnostics of colorectal cancer by genomic arrays: proposal for a procedural shift in biological sampling and pathological report. Ital J Anat Embryol (2010) 0.75
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose. Am J Ther (2016) 0.75
Bradykinin and tachykinin-induced leukotriene release in airway virus infections. Am J Respir Crit Care Med (2005) 0.75
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux. J Breath Res (2016) 0.75
A case of pulmonary Langerhans cell histiocytosis in a young woman with coeliac disease. Swiss Med Wkly (2007) 0.75
Brugada-like electrocardiographic pattern: a challenge for the clinician. Eur J Intern Med (2006) 0.75